Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Finance
    3. >US Supreme Court to hear Bayer's bid to curb Roundup cases
    Finance

    US Supreme Court to Hear Bayer's Bid to Curb Roundup Cases

    Published by Global Banking & Finance Review®

    Posted on January 16, 2026

    4 min read

    Last updated: January 19, 2026

    Add as preferred source on Google
    US Supreme Court to hear Bayer's bid to curb Roundup cases - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:EPAinsurancefinancial managementinvestmentcorporate governance

    Quick Summary

    The US Supreme Court will review Bayer's appeal to limit lawsuits claiming Roundup causes cancer, potentially impacting 65,000 similar cases.

    US Supreme Court to Review Bayer's Appeal on Roundup Lawsuits

    Bayer's Legal Challenges and Supreme Court Involvement

    By Diana Novak Jones

    Background of the Roundup Lawsuits

    Jan 16 (Reuters) - The U.S. Supreme Court agreed on Friday to hear Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.

    Arguments Presented by Bayer

    The justices took up Bayer's appeal of a lower court's ruling in a case brought by a man who said he was diagnosed with non-Hodgkin's lymphoma after years of exposure to Roundup.

    Impact of EPA Findings on Litigation

    The Missouri Court of Appeals rejected the German pharmaceutical and biotechnology company's contention that federal law governing pesticides bars lawsuits making claims over pesticides under state laws. 

    Potential Consequences for Bayer

    Bayer is facing similar claims from approximately 65,000 plaintiffs in U.S. state and federal courts. Roundup is among the most widely used weedkillers in the United States.

    President Donald Trump's administration in December urged the Supreme Court to take up Bayer's appeal. In a brief filed at the court, U.S. Solicitor General D. John Sauer offered the administration's view that Bayer is correct in its reading of the law at issue.

    Bayer is arguing that consumers should not be able to sue it under state law for failing to warn that Roundup increases cancer risk because the U.S. Environmental Protection Agency has found no such risk and requires no such warning. Bayer argued that federal law does not allow it to add any warning to the product beyond the EPA-approved label.

    The company has made the U.S. Supreme Court a key part of its strategy to manage the claims, as a ruling that federal law preempts claims brought under state law would shut down the vast majority of the lawsuits. Monsanto said different courts have come down on opposite sides of the issue.

    In the case of plaintiff John Durnell, the Missouri Court of Appeals upheld a $1.25 million verdict that a St. Louis jury awarded him over his cancer diagnosis. 

    Lawyers for Durnell had asked the Supreme Court to turn away Bayer's appeal. They said Durnell relied on Bayer's advertising and not just the label when he chose to use Roundup, and the company's marketing failed to warn consumers of the product's risks.

    The company has paid about $10 billion to settle most of the Roundup lawsuits that were pending as of 2020, but failed to get a settlement covering future cases. New lawsuits have continued to pour in since then. Plaintiffs have said they developed non-Hodgkin's lymphoma and other forms of cancer due to using Roundup, either at home or on the job.

    Bayer, which acquired Roundup as part of its $63 billion purchase of agrochemical company Monsanto in 2018, has said that decades of studies have shown Roundup and its active ingredient, glyphosate, are safe for human use.

    "EPA has repeatedly determined that glyphosate is not likely to be carcinogenic in humans, and the agency has repeatedly approved Roundup labels that did not contain cancer warnings," Sauer said in the administration's brief to the Supreme Court.

    The company has had a mixed record at trial in the Roundup lawsuits. Bayer has prevailed in a series of Roundup trials, but it was also hit with large jury awards in the past few years, including a $2.1 billion verdict in a case in the U.S. state of Georgia in 2025. 

    Bayer has asked the Supreme Court to consider the Roundup litigation before, but was rebuffed in 2022. Since then, one federal appeals court agreed with the company in a split from other appeals courts. 

    Bayer has threatened to withdraw Roundup from the U.S. market as it fights the litigation. The company replaced glyphosate in U.S. consumer products with different weed-killing substances.

    (Reporting by Diana Novak Jones in Chicago; Additional reporting by Andrew Chung; Editing by Will Dunham)

    Table of Contents

    • Bayer's Legal Challenges and Supreme Court Involvement
    • Background of the Roundup Lawsuits
    • Arguments Presented by Bayer
    • Impact of EPA Findings on Litigation

    Key Takeaways

    • •US Supreme Court to hear Bayer's appeal on Roundup lawsuits.
    • •Bayer aims to limit cancer claims linked to Roundup.
    • •EPA findings play a crucial role in the legal battle.
    • •Bayer faces 65,000 similar claims in US courts.
    • •Company has paid $10 billion to settle past lawsuits.

    Frequently Asked Questions about US Supreme Court to hear Bayer's bid to curb Roundup cases

    1What is Roundup?

    Roundup is a widely used herbicide produced by Bayer, primarily containing glyphosate, which is used to kill weeds and grasses.

    2What is non-Hodgkin's lymphoma?

    Non-Hodgkin's lymphoma is a type of cancer that originates in the lymphatic system, which is part of the body's immune system.

    3
    Potential Consequences for Bayer
    What are federal laws governing pesticides?

    Federal laws governing pesticides regulate the use, distribution, and labeling of pesticides to ensure safety and efficacy, primarily enforced by the EPA.

    4What is preemption in legal terms?

    Preemption is a legal doctrine where federal law overrides state law, preventing states from making conflicting regulations.

    More from Finance

    Explore more articles in the Finance category

    Image for ECB may need to act on even 'not-too-persistent' inflation surge, Lagarde says
    ECB May Need to Act on Even 'not-Too-Persistent' Inflation Surge, Lagarde Says
    Image for Europe's STOXX 600 gains 1% on prospect of Middle East ceasefire
    Europe's Stoxx 600 Gains 1% on Prospect of Middle East Ceasefire
    Image for Estonia says drone enters from Russia, hits power station, ERR reports
    Estonia Says Drone Enters From Russia, Hits Power Station, Err Reports
    Image for Germany's Aurelius interested in buying Carrefour's Belgian unit, L'Echo reports
    Germany's Aurelius Interested in Buying Carrefour's Belgian Unit, L'Echo Reports
    Image for Germany's EnBW expects profits to be stable at best in 2026
    Germany's EnBW Expects Profits to Be Stable at Best in 2026
    Image for UK, EU and Switzerland set out one-day settlement testing plan
    Uk, EU and Switzerland Set Out One-Day Settlement Testing Plan
    Image for Taiwan wary that China could exploit US distraction over Middle East war
    Taiwan Wary That China Could Exploit US Distraction Over Middle East War
    Image for Russian attacks knock out power for thousands in Ukraine's north
    Russian Attacks Knock Out Power for Thousands in Ukraine's North
    Image for UK's Headlam warns of revenue drop as Middle East war pushes costs higher
    UK's Headlam Warns of Revenue Drop as Middle East War Pushes Costs Higher
    Image for Hedge fund founder Odey gives evidence in fight against financial industry ban
    Hedge Fund Founder Odey Gives Evidence in Fight Against Financial Industry Ban
    Image for UK's RS Group forecasts annual profit marginally ahead of market view
    UK's Rs Group Forecasts Annual Profit Marginally Ahead of Market View
    Image for Spanish gambling group Codere to go on sale for $2.3 billion, Expansion reports
    Spanish Gambling Group Codere to Go on Sale for $2.3 Billion, Expansion Reports
    View All Finance Posts
    Previous Finance PostEuropean Regulator Warns Airlines Not to Fly in Iranian Airspace
    Next Finance PostExclusive-Shell, Mitsubishi Exploring Sale Options for Their Stakes in Lng Canada, Sources Say